US Animal Model Market is predicted to value at US$ 1,487.9 million by 2033, with a CAGR of 4.3%

In 2022, the US Animal Model Market size was valued at approximately US$ 947.3 million. From 2023 to 2033, demand for Animal Models in the United States is expected to rise at a 4.3% CAGR. The value of demand for Animal Models in the United States is expected to reach US$ 1,487.9 million by 2033. According to Future Market Insights, mice will account for more than 61.03% of the market in the United States in 2022.

Animal Models are predominantly used to gather information regarding the disease and its prevention, diagnosis, and treatment. They are being used to resolve a wide range of scientific concerns, ranging from basic science to the discovery and evaluation of new vaccines and therapies. Animals are used because of the similarities in biology across most mammals.

Get Full PDF Sample Copy of Latest Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14527

Personalised medicine, often known as precision medicine, is the use of data about a specific patient or an individual’s genes to determine illness therapy. Animal Models can play a significant role in the development of novel personalised medical techniques. Increased use of personalised medicine will drive Animal Model sales in the future years.

Animal toxicity testing is performed to identify potential negative effects of an agent’s exposure and to create dose-response associations. Animal testing is vital for early detection of potential human risks or as models for studying illness aetiology, pathophysiology, development, and treatment.

The Federal Food, Drug, and Cosmetic Act (FFDCA), the Environmental Protection Agency (EPA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and the Organisation for Economic Cooperation and Development (OECD) set the guidelines for animal toxicity testing.

Some factors expected to drive market growth include the high volume of chemicals tested in the United States, the increased generation and use of novel GM animal strains in toxicity studies, and the development and attempted validation of several animal tests to screen chemicals for endocrine (hormone)-disrupting activity.

Key Takeaways:

• In terms of species, the mice model category held a market share of approximately 61.03% in 2022, with sales expected to grow at a 5.1% annual rate through 2033.
• Oncology held roughly 32.6% of the total market share in 2022, and this trend is likely to continue throughout the forecast period.
• Total Animal Model sales in the drug discovery/development sector accounted for 65.4% of total market share in 2022.
• Demand in the academic & research institutes segments was approximately 37.21% of the total market share in 2022, based on end users.

For any queries linked with the report, ask an analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14527

Market Competition

Key players operating in the US Animal Model market are expanding their business through partnerships and acquisitions with other companies to improve their global footprint. Following are a few examples of acquisitions:

• In October 2021, The Jackson Laboratory completed the acquisition of Charles River Laboratories Japan’s Research Models & Services (RMS), which allows advancement in the company’s scientific improvements in basic research and drug discovery.
• In November 2021, Inotiv, Inc., which is a leading contract research organization (CRO) completed its acquisition of Envigo RMS Holding Corp. to expand its R&D sector.
• In February 2021, Biocytogen completed the acquisition of a third Beacon Optofluidic system. This acquisition expanded Biocytogen’s service platform in the Boston area.

Key Players:

• Charles River Laboratories
• The Jackson Laboratory
• Taconic Biosciences, Inc.
• Genoway
• Envigo (Inotiv, Inc.)
• Marshall BioResources
• Janvier Labs
• Applied stem cells
• Biocytogen
• Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
• Cyagen
• Ingenious targeting labs
• Crown Bioscience Inc. (JSR Corporation).
• Harbour Biomed
• Sinclair Bio Resources
• Alpha Genesis Inc.
• Creative Animodel
• DaVinci Biomedical Research Products, Inc

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Animal Model market in its latest study, presenting a historical demand assessment of 2018 to 2022 and projections for 2023 to 2033.

For in-depth competitive analysis, Buy Now@ https://www.futuremarketinsights.com/checkout/14527

Key Segments Covered by USA Animal Model Industry Survey Report

By Species:

• Mice
• Rats
• Fish
• Birds
• Cattles
• Pigs
• Amphibians
• Guinea Pigs
• Dogs
• Cats
• Rabbits
• Monkeys
• Sheep
• Hamsters
• Other Animals

By Technology:

• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
• Microinjection
• Nuclear Transfer
• Other Technologies

By Application:

• Research & Development
  • Infectious Disease
  • Immunological Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Genetic Diseases
  • Neurological Diseases
  • Obesity
  • NAFLD or NASH
  • Renal disease
  • Diabetic eye disease
  • Fibrosis
  • Micro-biome
  • Other Research and Developments
• Production and Quality Control
• Academics
• Preclinical Applications
  • Infectious Disease
  • Immunological Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Genetic Diseases
  • Neurological Diseases
  • Obesity
  • NAFLD/NASH
  • Renal disease
  • Diabetic eye disease
  • Fibrosis
  • Micro-biome
  • Other Preclinical Applications
• Other Applications

By Use:

• Human
• Veterinary

By End-user Verticals:

• Companies
  • Pharmaceutical
  • Biotechnology
  • Cosmetics
  • Other Companies
• Organizations
  • Government
  • Non-government
• Academic and Research Institutes
• Contract Research Organizations (CRO)

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs